Alphabet’s Verily Life Sciences racks up $700m: Reuters

Verily Life Sciences LLC, Alphabet Inc’s life sciences division, has raised $700 million in funding, reported Reuters.

Verily Life Sciences LLC, Alphabet Inc’s life sciences division, has raised $700 million in funding, reported Reuters. The backers include Alphabet, Silver Lake and Temasek. The news wire noted that Verily had developed a COVID-19 test, “which was granted an emergency use authorization by the U.S. Food and Drug Administration in September.”

Source: Reuters